Lansforsakringar Fondforvaltning Ab (Publ) Biogen Inc. Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $17 Billion
- Q2 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Biogen Inc. stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 47,747 shares of BIIB stock, worth $7.48 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
47,747
Previous 48,132
0.8%
Holding current value
$7.48 Million
Previous $6.59 Million
8.96%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,055Shares Held
131MCall Options Held
2.84MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.71 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.48 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.28 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.17 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$752 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...